Eighty canine epithelial colorectal tumors obtained by excisional biopsy were evaluated immunohistochemically for p53 tumor suppressor gene protein. Dogs in the study averaged 6.9 years of age (range, 1-12.5 years). A standard avidin-biotin immunohistochemical protocol incorporated a polyclonal antibody of rabbit origin (CM-1) as the primary antibody. Positive staining was observed within all subcategories of lesions, including hyperplastic polyps 1/2 (50%), adenomas 14/29 (48%), carcinomas in situ 9/22 (41%), adenocarcinomas 3/4 (75%), and invasive carcinomas 8/23 (35%). A total of 35/80 (44%) positive tumors were identified. Fifteen of 31 (48%) benign tumors labeled for p53 protein compared to 20/49 (41%) malignant tumors. Survival data was available for 57/80 (71%) dogs. The average age of dogs within the group with survival data was 4.4 years. Males predominated 34/57 (60%). Mean survival time was 20.6 months. There was no significant difference in survival time between dogs grouped according to p53 immunoreactivity, cellular stain location, or tumor site. A statistically significant increase in survival time was observed between dogs with clean surgical margins and those without (P < 0.018) and for dogs with adenomas or carcinomas in situ over dogs with invasive carcinomas (P < 0.02). In this study, the overall greater positive staining frequency of benign lesions compared to malignant lesions is contrary to data derived from similar immunohistochemical analyses of human tumors and is incongruous with the theorized late-stage participation of the p53 protein in the development of human colorectal cancers. The results of this study suggest that if the p53 tumor suppressor gene protein is involved in the progression of canine colorectal tumors, it may play a relatively early role, possibly analogous to the early appearance of p53 overexpression in precancerous lesions of human ulcerative colitis. Immunohistochemical detection of p53 was not useful prognostically.
AjiokaYWatanabeHMatsudaK:
Over-expression of p53 protein in neoplastic changes in ulcerative colitis: immunohistochemical study.
J Gastroenterol30(Suppl 8):33–35, 1995
2.
AngelopoulouKDiamandisEPSutherlandDJAKellenJABuntingPS:
Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers.
Int J Cancer58:480–487, 1994
3.
AprikianAGSarkisASFairWRZhangZFuksZCordon-CardoC:
Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma.
J Urol151:1276–1280, 1994
4.
AuvinenAIsolaJVisakorpiTKoivulaTVirtanenSHakamaM:
Overexpression of p53 and long-term survival in colon carcinoma.
Br J Cancer70:293–296, 1994
5.
BakerSJMarkowitzSFearonER:
Colon cancer and the p53 oncogene.
Gastroenterology100:842–843, 1991
6.
BarkerIKvan DreumelAAPalmerN:
The alimentary system. In:
Pathology of the Domestic Animals,
ed. JubbKVFKennedyPCand PalmerN,
4th ed.,
pp. 133–136,
Academic Press, San Diego, CA,
1993
7.
BartekJBartkovaBVojtesekZStaskovaZLukasJRejtharAKovarikJMidgleyCAGannonJVLaneDP:
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Oncogene6:1699–1703, 1991
8.
BatraSKAhmed RasheedBKBignerSHBignerDD:
Oncogenes and anti-oncogenes in human central nervous system tumors.
Lab Invest71:621–637, 1994
9.
BaytnerSMitmakerBGordonPHWangE:
Immunohistochemical expression of p53 oncogene in transitional mucosa adjacent to human colon cancer.
Clin Invest Med16:379–385, 1993
10.
BosariSVialeGBossiPMaggioniMCoggiGMurrayJJLeeAK:
Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
J Natl Cancer Inst86:681–686, 1994
11.
BosariSVialeGRoncalliMGrazianiDBorsaniGLeeAKCoggiG:
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma.
Am J Pathol147:790–798, 1995
12.
BrentnallTACrispinDARabinovitchPSHaggittRCRubinCEStevensACBurmerGC:
Mutations in th p53 gene: an early marker of neoplastic progression in ulcerative colitis.
Gastroenterology107:369–378, 1994
13.
ChinKUedaKPastanIGottesmanMM:
Modulation of activity of the promoter of the human MDR1 gene by ras and p53.
Science255:459–462, 1992
14.
ChurchEMMehlhaffCJPatnaikAK:
Colorectal adenocarcinoma in dogs: 78 cases (1973-1984).
J Am Vet Med Assoc191:727–730, 1987
15.
CohenCDeRosePB:
Immunohistochemical p53 in hepatocellular carcinoma and liver cell dy lasia.
Mod Pathol7:536–539, 1994
16.
Cordon-CardoC:
Mutations of cell cycle regulators: biological and clinical implications for human neoplasia.
Am J Pathol147:545–560, 1995
17.
CoxLAChenGLeeEY-HP:
Tumor suppressor genes and their roles in breast cancer.
Breast Cancer Res Treat32:19–38, 1994
18.
DittmerDPatiSZambettiGChuSTereskyAKMooreMFinlayCLevineAJ:
Gain of function mutations in p53.
Nat Genet4:42–45, 1993
19.
DixonWJ:
Survival analysis in BMDP Statistical Software, p. 555.
University of California Press, Berkeley, CA,
1981
20.
DonehowerLAHarveyMSlagleBLMcArthurMJMongomeryCAJrButelJSBradleyA:
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
Nature356:215–221, 1992
21.
EvansHJProsserJ:
Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers.
Environ Health Perspect98:25–37, 1992
22.
Fenoglio-PreiserCMLantzPEListromMBDavisMRilkeFO:
Gastrointestinal Pathology: An Atlas and Text, pp. 729–745,
760–763.
Raven Press, New York, NY,
1989
23.
FroggatNJLevssenSHGarnerRE:
Low frequency and late occurrence of p53 and dec aberrations in colorectal tumours.
Cancer Res Clin Oncol121:7–15, 1995
24.
GamblinRMSagartzJECoutoCG:
p53 tumor suppressor protein overexpression in spontaneous neoplasms of dogs: an immunohistochemical survey. In:
Proceedings of the Veterinary Cancer Society 15th Annual Conference, October 21–24, Tucson, AZ, 15:83–84, 1995
25.
HamiltonSR:
Molecular genetics of colorectal carcinoma.
Cancer70(Suppl 5):1216–1221, 1992
26.
HeadKW:
Tumors of the alimentary tract. In:
Tumors in Domestic Animals,
ed. MoultonJE,
3rd ed., pp. 398–412,
University of California Press, Berkeley, CA,
1990
27.
HindsPWFinlayCAQuartinRSBakerSJFearonERVogelsteinBLevineAJ:
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Cell Growth Differ1:571–580, 1990
28.
HollsteinMSidranskyDVogelsteinBHarrisCC:
p53 mutations in human cancers.
Science253:49–53, 1991
29.
HoltPELuckeVM:
Rectal neoplasia in the dog: a clin-icopathological review of 31 cases.
Vet Rec116:400–405, 1985
30.
HomerBL:
Epithlelial tumors of the colon and rectum in the dog. In:
Abstracts of the Forty-first Annual Meeting of the American College of Veterinary Pathologists, December 9–14, Phoenix, AZ, 1990
31.
KaklamanisLGatterKCMortensenNBaigrieRJHeryetALaneDPHarrisAL:
p53 expression in colorectal adenomas.
Am J Pathol142:87–93, 1993
32.
KaplanEFMeierF:
Non-parametric estimation from incomplete observations.
J Am Stat Assoc53:457, 1958
33.
KernSERedstonMSeymourABCaldasCPowellSMKomackiSKinzlerKW:
Molecular genetic profiles of colitis-associated neoplasms.
Gastroenterology107:420–428, 1994
34.
KoefflerPMcCormickFDennyC:
Molecular mechanisms of cancer.
Western J Med155:505–514, 1991
35.
LingemanCHGamerFM:
Comparative study of intestinal adenocarcinomas of animals and man.
J Natl Cancer Inst48:325–346, 1972
36.
LynchHTWatsonPSmyrkTCLanspaSJBomanBMBolandCRLynchJFCavalieriRJLeppertMWhiteRSidranskyDVogelsteinB:
Colon cancer genetics.
Cancer70(Suppl 5):1300–1312, 1992
37.
MagrissoIJRichmondRECarterJHProssCBGilfillenRACarterHW:
Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Lab Invest69:674–681, 1993
38.
MarxJ:
Test could yield improved colon cancer detection.
Science256:32, 1992
39.
MayrBSchellanderKSchlegerWReifingerM:
Sequence of an exon of the canine p53 gene: mutation in a papilloma.
Br Vet J150:81–84, 1994
40.
OhueMTomitaNMondenTFujitaMFukunagaMTakamiKYanaIOhnishiTEnomotoTInoueMShimanoTMoriT:
A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Cancer Res54:4798–4804, 1994
41.
PatnaikAK:
Canine intestinal adenocarcinoma and carcinoid.
Vet Pathol17:149–163, 1980
42.
PoriesSESummerhayesICSteeleGD:
Oncogene-mediated transformation: an in-vitro model of colon carcinogenesis.
Arch Surg.126:1387–1389, 1991
43.
ProkocimerMRotterV:
Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages.
Blood84:2391–2411, 1994
44.
PurdieCAO'GradyJPirisJWyllieAHBirdCC:
p53 expression in colorectal tumors.
Am J Pathol138:807–809, 1991
45.
RosnerB:
Fundamentals of Biostatistics, p. 370.
Wads-worth Publishing Co., Belmont, CA,
1995.
46.
SagartzJEBodleyWLGamblinRMCoutoCGTierneyLACapenCC:
p53 tumor suppressor protein over-expression in osteogenic tumors of dogs.
Vet Pathol33:213–221, 1996
47.
SeilerRJ:
Colorectal polyps of the dog: a clinicopathologic study of 17 cases.
J Am Vet Ned Assoc174:72–75, 1979
48.
ShawPBoveyRTardySSahliRSordatBCostaJ:
Induction of apoptosis by wild-type p53 in a human colon tumor derived cell line.
Proc Natl Acad Sci USA89:4495–4499, 1992
49.
SilverbergSG.
Carcinoma arising in adenomatous polyps of the rectum in a dog.
Dis Colon Rectum14:191–194, 1971
50.
SoussiTde FromentelCCNayP:
Structural aspects of the p53 protein in relation to gene evolution.
Oncogene5:945–952, 1990
51.
SunXCarstensenJMStalOZhangHNilssonESjodahlRNordenskholdB:
Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
Virchows Arch A Pathol Anat Histopathol423:443–448, 1993
52.
TeradaTShimizuKRyoheiINakanumaY:
p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
Mod Path7:249–252, 1994
53.
TiemannFZerrahnJDeppertW:
Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation.
J Virol9:6115–6121, 1995
54.
TominagaOHamelinRTrouvatVSalmonRJLesecGThomasGRemvikosY:
Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas.
Oncogene8:2653–2658, 1993
55.
ValeriusKDPowersBEMcPherronMAMannFAWithrowSJ:
Adenomatous polyps and carcinoma in situ of the canine rectum.
Proceedings of the Veterinary Cancer Society14:12–13, 1994
56.
van den BergFMBaasIOPolakMMOfferhausGJA:
Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.
Am J Pathol142:381–385, 1993
57.
van den BergFMTiggesAJSchipperMEIden Hartog-JagerFCAKroesWGMWalboomersJMM:
Expression of the nuclear oncogene p53 in colon tumors.
J Pathol157:193–199, 1989
58.
van der GaagI:
The histological appearance of large intestinal biopsies in dogs with clinical signs of large bowel disease.
Can J Vet Res52:75–82, 1988
59.
VogelsteinBFearonERHamiltonSRKemSEPreis-ingerACLeppertMNakamuraYWhiteRSmitsAMMBosJL:
Genetic alterations during colorectal tumor development.
N Engl J Med319:525–532, 1988
60.
WinawerSJ:
Neoplasms of the large and small intestine. In:
Cecil Textbook of Medicine,
ed. WyngaardenJBSmithLHJr,
18th ed., WB Saunders, Philadephia, PA,
1988
61.
YaremkoMLWasylyshynMLWestbrookCAMichelassiF:
Oncogenes, suppressor genes, and allele losses in colon cancer.
Adv Surg26:323–332, 1993
62.
YinJHarpazNTongYHuangYLaurinJGreenwaldBDHontanosasMNewkirkCMeltzerSJ:
p53 point mutations in dysplastic and cancerous ulcerative colitis lesions.
Gastroenterology104:1633–1639, 1993
